Asia-Pacific stocks set to open mixed as global concerns persist

Asia-Pacific stocks set to open mixed as global concerns persist


SINGAPORE — Shares in the Asia-Pacific region were poised to open mixed on Monday as global concerns continue to plague markets.

In Japan markets, the Nikkei futures contract in Chicago was at 26,920, while its counterpart in Osaka was at 26,750. The Nikkei 225 closed at 26,739.03 on Friday.

Australia’s SPI futures were at 7,129, lower compared to the S&P/ASX 200’s last close at 7,145.6.

Chinese electric vehicle maker Xpeng is set to report its first-quarter earnings on Monday.

Stocks stateside have been taking a battering as markets grow fearful over whether there will be a recession.

Stock picks and investing trends from CNBC Pro:

In the U.S., the S&P 500 briefly fell into bear market territory during Friday’s session, but recovered slightly to close almost flat. The Dow Jones Industrial Average rose 8.77 points to 31,261.90 after reversing losses of more than 600 points.

The Nasdaq Composite is already deep in bear market territory, 30% off its highs, and fell 0.3% on Friday. All three indexes have posted at least a seven-week losing streak.

Currencies



Source

U.S. and Iran haven’t backed ceasefire idea as Trump’s Hormuz Strait deadline nears
World

U.S. and Iran haven’t backed ceasefire idea as Trump’s Hormuz Strait deadline nears

US President Donald Trump disembarks from Air Force One upon arrival at Joint Base Andrews in Maryland, March 23, 2026. Saul Loeb | Afp | Getty Images President Donald Trump has not backed an idea for a 45-day ceasefire that would take effect before his upcoming deadline for Iran to either reopen the Strait of […]

Read More
S&P 500 rises as investors await possible Iran and U.S. ceasefire: Live updates
World

S&P 500 rises as investors await possible Iran and U.S. ceasefire: Live updates

Traders work on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York on April 2, 2026. Charly Triballeau | Afp | Getty Images The S&P 500 rose on Monday following a winning week as oil prices pulled back, with traders weighing the odds that the U.S.-Iran war could […]

Read More
Neurocrine expands into metabolic diseases with .9 billion Soleno buyout
World

Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout

Piotr Swiat | Lightrocket | Getty Images Neurocrine Biosciences will acquire rare-disease drugmaker ⁠Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused ​drugmaker’s expansion into ​metabolic disorders. The deal ​gives Neurocrine access to Vykat XR, the first drug approved in the U.S. to treat hyperphagia associated with Prader-Willi syndrome, […]

Read More